Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 4/2002

01-05-2002

Mast Cells Derived from Embryonic Stem Cells: A Model System for Studying the Effects of Genetic Manipulations on Mast Cell Development, Phenotype, and Function In Vitro and In Vivo

Authors: Mindy Tsai, See-Ying Tam, Jochen Wedemeyer, Stephen J. Galli

Published in: International Journal of Hematology | Issue 4/2002

Login to get access
Metadata
Title
Mast Cells Derived from Embryonic Stem Cells: A Model System for Studying the Effects of Genetic Manipulations on Mast Cell Development, Phenotype, and Function In Vitro and In Vivo
Authors
Mindy Tsai
See-Ying Tam
Jochen Wedemeyer
Stephen J. Galli
Publication date
01-05-2002
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 4/2002
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/BF02982122

Other articles of this Issue 4/2002

International Journal of Hematology 4/2002 Go to the issue

Case Report

Human Herpesvirus 6 Meningoencephalitis Successfully Treated with Ganciclovir in a Patient Who Underwent Allogeneic Bone Marrow Transplantation from an HLA-Identical Sibling

Case Report

Diagnostic Significance of Measurement of the Receptor for Urokinase-Type Plasminogen Activato on Granulocytes and in Plasma from Patients with Paroxysmal Nocturnal Hemoglobinuria

Review Article

Leukemogenic Risk of Hydroxyurea Therapy as a Single Agent in Polycythemia Vera and Essential Thrombocythemia: N-and K-ras Mutations and Microsatellite Instability in Chromosomes 5 and 7 in 69 Patients

Case Report

Nationwide Study of Idiopathic Thrombocytopenic Purpura in Pregnant Women and the Clinical Influence on Neonates

Review Article

Signal Transduction of Chemokine Platelet Factor 4 in Human Erythroleukemia Cells

Case Report

Sodium Salicylate—Triggered Apoptosis in HL-60 Cells Depends on Caspase-8 Activation
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits